SCHEMBL4434781

SCHEMBL4434781

NC(=O)CNC(=O)c1cnn2cc(Cc3ccc(Cl)c(C(F)(F)F)c3)cnc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 2/20 0.47
PDE2A O00408 2/20 0.42
KDM4A O75164 1/20 0.38
KDM5A P29375 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
AURKA O14965 3/20 0.38
RPS6KB1 P23443 3/20 0.38
AURKB Q96GD4 2/20 0.38
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
BRAF P15056 2/20 0.36
PKM P14618 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
SCN3A Q9NY46 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4444836 0.90 PDE2A (0.43) NR3C1PDE2ARPS6KB1
SCHEMBL14033169 0.89 PDE2A (0.42) PDE2AKDM4EHPGDALDH1A1PKM
SCHEMBL4439750 0.86 PDE2A (0.41) PDE2AKDM4EPKMHSD17B10IRAK4
SCHEMBL14033857 0.85 KDM4A (0.50) NR3C1PDE2AKDM4AKDM5AKDM5B
SCHEMBL4437012 0.85 KLKB1 (0.42) NR3C1PDE2AKDM4EHPGDALDH1A1
SCHEMBL4437368 0.85 MRGPRX4 (0.42) PDE2AKDM4EPKMHSD17B10
SCHEMBL14033455 0.81 IRAK4 (0.43) PDE2AKDM4EPKMHSD17B10IRAK4
SCHEMBL14033167 0.79 PDE2A (0.41) PDE2AKDM4EPKMHSD17B10IRAK4
SCHEMBL14033701 0.79 IRAK4 (0.43) PDE2AKDM4EPKMHSD17B10IRAK4
SCHEMBL4439128 0.79 PDE2A (0.48) NR3C1PDE2AKDM4AKDM5AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137187-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE Inovacia AB (SE) 2009-12-30 EP claimed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO claimed
EP-2137187-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE Inovacia AB (SE) 2009-12-30 EP disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255153-A1 New compounds SCD, SCD5, FADS2 NR3C1 2779/4885PDE2A 2511/4885KDM4A 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.